Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 2
Journal homepage
14,640
Views
118
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review

Atsushi Ogata Division of Rheumatology, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan; ;Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3944-3442
ORCID Icon,
Yasuhiro Kato Division of Rheumatology, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan; ;Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; ORCID Iconhttp://orcid.org/0000-0002-4050-2350
ORCID Icon,
Shinji Higa Division of Rheumatology, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan;
&
Kazuyuki YoshizakiGraduate School of Information Science and Technology, Osaka University, Osaka, Japan
Pages 258-267 | Received 12 Sep 2018, Accepted 31 Oct 2018, Published online: 03 Jan 2019

Citations (118)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Sai Krishna Srimadh Bhagavatham, Sujith Kumar Pulukool, Sai Sanwid Pradhan, Saiswaroop R.Ashwin Ashok Naik, Datta Darshan V. M.Venketesh Sivaramakrishnan. (2023) Systems biology approach delineates critical pathways associated with disease progression in rheumatoid arthritis. Journal of Biomolecular Structure and Dynamics 41:14, pages 6969-6990.
Read now
Ryu Watanabe, Kosaku Murakami, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, Akio Morinobu & Motomu Hashimoto. (2023) Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort. Immunological Medicine 46:2, pages 84-92.
Read now
Aya M. Al-Rahim, Rawaa AlChalabi, Ali Z. Al-Saffar, Ghassan M. Sulaiman, Salim Albukhaty, Tareg Belali, Elsadig M. Ahmed & Khalil A. A. Khalil. (2023) Folate-methotrexate loaded bovine serum albumin nanoparticles preparation: an in vitro drug targeting cytokines overwhelming expressed immune cells from rheumatoid arthritis patients. Animal Biotechnology 34:2, pages 166-182.
Read now
Satoshi Morinaka, Hiroto Tsuboi, Shinya Hagiwara, Toshiki Sugita, Daiki Tabuchi, Ryota Sato, Taihei Nishiyama, Shota Okamoto, Toshihiko Terasaki, Mizuki Yagishita, Hiroyuki Takahashi, Yuya Kondo, Isao Matsumoto & Takayuki Sumida. (2021) Clinical features of large vessel vasculitis (LVV): Elderly-onset versus young-onset. Modern Rheumatology 31:6, pages 1129-1134.
Read now
HB Hammer, IMJ Hansen, P Järvinen, M Leirisalo-Repo, M Ziegelasch, B Agular & L Terslev. (2021) Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 50:4, pages 262-270.
Read now
Atsushi Ogata, Yasuhiro Kato, Shinji Higa & Keiji Maeda. (2019) Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis. Expert Opinion on Drug Delivery 16:6, pages 639-648.
Read now

Articles from other publishers (112)

Jianbei Xi, Hongliang Gong, Zheng Li, Yue Li, Yong Wu, Yong Zhang, Jian-Fei Wang & Guo-Huang Fan. (2023) Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry.
Crossref
Desh Nepal & David Gazeley. (2023) Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus. Rheumatology 62:12, pages 3804-3810.
Crossref
Federico Díaz-González & María V. Hernández-Hernández. (2023) Artritis reumatoide. Medicina Clínica 161:12, pages 533-542.
Crossref
Xiaoqing Wang, Xiu Gu & Fengli Liu. (2023) IL-6 gene polymorphism predicts PEGylated IFN-α treatment response in hepatitis B surface antigen-positive chronic hepatitis B patients . Personalized Medicine.
Crossref
Smriti Mohan. (2023) Targeted Treatment of Diseases of Immune Dysregulation. Rheumatic Disease Clinics of North America 49:4, pages 913-929.
Crossref
Federico Díaz-González & María V. Hernández-Hernández. (2023) Rheumatoid arthritis. Medicina Clínica (English Edition).
Crossref
Mei Liu, Qing Wang, Wanai Xu, Jingyu Wu, Xingyue Xu, Hongjun Yang & Xianyu Li. (2023) Natural products for treating cytokine storm–related diseases: Therapeutic effects and mechanisms. Biomedicine & Pharmacotherapy 167, pages 115555.
Crossref
Yuyi Xu, Ming Zhao, Jinxue Cao, Ting Fang, Jian Zhang, Yanli Zhen, Fangling Wu, Xiaohui Yu, Yaming Liu, Ji Li & Dongkai Wang. (2023) Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Acta Pharmaceutica Sinica B 13:11, pages 4417-4441.
Crossref
Prerna Sharma, Rahul V. Joshi, Robert Pritchard, Kevin Xu & Maya A. Eicher. (2023) Therapeutic Antibodies in Medicine. Molecules 28:18, pages 6438.
Crossref
Masayoshi Harigai, Takako Miyamae, Hideyuki Hashimoto, Kosei Umetsu, Katsuhisa Yamashita & Yoshikazu Nakaoka. (2023) A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan. Modern Rheumatology.
Crossref
Hamidreza Ebrahimian, Maryam Akhtari, Maassoumeh Akhlaghi, Elham Farhadi, Ahmadreza Jamshidi, Gholam Hossein Alishiri, Mahdi Mahmoudi & Mahmood Tavallaie. (2023) Altered expression of apoptosis‐related genes in rheumatoid arthritis peripheral blood mononuclear cell and related miRNA regulation. Immunity, Inflammation and Disease 11:7.
Crossref
C.S. Sharanya, J. Abhithaj, K.G. Arun, Koti Reddy Eeda, Vignesh Bhat, E.J. Variyar, A. Sabu & M. Haridas. (2023) Lipoxygenase inhibitory synthetic derivatives of methyl gallate regulate gene expressions of COX-2 and cytokines to reduce animal model arthritis. Scientific Reports 13:1.
Crossref
Sotaro Ozaka, Masahide Fukuda, Haruhiko Takahashi, Koshiro Tsutsumi, Masao Iwao, Yuka Hirashita, Kensuke Fukuda, Kazuhisa Okamoto, Mie Arakawa, Ryo Ogawa, Mizuki Endo, Kazuhiro Mizukami, Naganori Kamiyama, Takashi Kobayashi, Masaaki Kodama & Kazunari Murakami. (2023) Tocilizumab-induced mucosal injury in the terminal ileum mimicking intestinal Behçet’s disease: A case report. Medicine 102:25, pages e34118.
Crossref
Siyuan Fan, Jiuliang Zhao, Bo Hou, Mange Liu, Jingwen Niu, Yan Zhou, Chenhui Mao, Haitao Ren, Feng Feng, Mengtao Li, Xiaofeng Zeng, Yicheng Zhu & Hongzhi Guan. (2023) Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis. Frontiers in Immunology 14.
Crossref
Enrico Gugliandolo, Francesco Macrì, Roberta Fusco, Rosalba Siracusa, Marika Cordaro, Ramona D’amico, Alessio Filippo Peritore, Daniela Impellizzeri, Tiziana Genovese, Salvatore Cuzzocrea, Rosanna Di Paola & Rosalia Crupi. (2023) Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension. Pharmacological Research 192, pages 106750.
Crossref
Tshimangadzo M. Denga, Sulè Gunter, Serena Fourie, Regina le Roux, Ashmeetha Manilall, Aletta M.E. Millen & Lebogang Mokotedi. (2023) Interleukin-6 Blockers Improve Inflammation-Induced Lipid Metabolism Impairments but Induce Liver Fibrosis in Collagen-Induced Arthritis. Endocrine, Metabolic & Immune Disorders - Drug Targets 23:4, pages 548-557.
Crossref
Ines Kralj-Hans, Kuo Li, Adrian Wesek, Alexia Lamorgese, Fatima Omar, Kapila Ranasinghe, Megan McGee, Kieran Brack, Shiliang Li, Ritesh Aggarwal, Ajay Bulle, Aparna Kodre, Shashank Sharma, David Fluck, Isaac John, Pankaj Sharma, Jonathan D Belsey, Ling Li, Sreenivasa Rao Kondapally Seshasai, Hong Lin Li, Nandor Marczin & Zhong Chen. (2023) Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial. BMJ Open 13:4, pages e068179.
Crossref
Amir Hossein Heydari, Sophia Heydari & Mohammad Esmaeil Heidari. (2021) Satralizumab, Novel Interleukine-6 Inhibitor for Preventing Descending Thoracic Aorta Aneurysm Development. Cardiovascular Drugs and Therapy 37:2, pages 239-244.
Crossref
Mustafa Erdoğan, Murat Günaltılı & Vedat Hamuryudan. (2023) Tocilizumab experience in patients with rheumatoid arthritis: A retrospective study. Ulusal Romatoloji Dergisi 15:1, pages 25-29.
Crossref
Xiao-Kai Chi, Xiao-Ling Xu, Bang-Yao Chen, Jin Su & Yong-Zhong Du. (2023) Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments. Journal of Nanobiotechnology 21:1.
Crossref
Romina Heydari, Fatemeh Koohi, Milad Rasouli, Kimia Rezaei, Elham Abbasgholinejad, Sander Bekeschus & Mohammad Doroudian. (2023) Exosomes as Rheumatoid Arthritis Diagnostic Biomarkers and Therapeutic Agents. Vaccines 11:3, pages 687.
Crossref
Yoshifumi Ohashi, Nobunori Takahashi, Yasumori Sobue, Mochihito Suzuki, Kyosuke Hattori, Kenji Kishimoto, Kenya Terabe, Shuji Asai, Toshihisa Kojima, Masayo Kojima & Shiro Imagama. (2023) Factors associated with frailty in rheumatoid arthritis patients with decreased renal function. Modern Rheumatology 33:2, pages 323-329.
Crossref
Kevin D. Burns & Adrianna Douvris. (2023) Protecting the kidney in sepsis: resident macrophages to the rescue. Kidney International 103:3, pages 461-463.
Crossref
Christa Burgos, Nelson Alvarenga, Pablo H. Sotelo & Patricia Langjahr. (2023) Anti-inflammatory activity of Baccharis notosergila against lipopolysaccharide (LPS)-induced inflammation and identification of active fractions and their chemical constituents. European Journal of Integrative Medicine 57, pages 102208.
Crossref
Vadim Gorodetskiy. 2023. Translational Autoimmunity. Translational Autoimmunity 221 231 .
Katie S. Turnbull & Martin E. Perry. 2023. Translational Autoimmunity. Translational Autoimmunity 181 205 .
Wolfgang LaubeWolfgang Laube. 2023. Bewegungsmangel. Bewegungsmangel 225 319 .
Guangqin Zhu, Shaopu Sui, Fengyun Shi & Qinglin Wang. (2022) Inhibition of USP14 suppresses ferroptosis and inflammation in LPS-induced goat mammary epithelial cells through ubiquitylating the IL-6 protein. Hereditas 159:1.
Crossref
Qinghong Ge, Xiuyu Gu, Wen Yu, Guoping Zhang, Wei Liang, Meifen Li, Guanghua Zhai & Meina Yan. (2022) Antinuclear antibodies in healthy population: Positive association with abnormal tissue metabolism, inflammation and immune dysfunction. International Immunopharmacology 113, pages 109292.
Crossref
Kaoru Yamagata, Shingo Nakayamada, Tong Zhang, Anh Phuong Nguyen, Naoaki Ohkubo, Shigeru Iwata, Shigeaki Kato & Yoshiya Tanaka. (2022) IL-6 production through repression of UBASH3A gene via epigenetic dysregulation of super-enhancer in CD4+ T cells in rheumatoid arthritis. Inflammation and Regeneration 42:1.
Crossref
Tatsuhiko Kutsuna, Kazunori Hino, Hitoshi Hasegawa, Kunihiko Watamori, Teruki Kidani, Hiroshi Imai & Hiromasa Miura. (2022) Psoriatic arthritis successfully treated with second-line anti-interleukin-6 treatment: a case report and review of the literature . Journal of Medical Case Reports 16:1.
Crossref
Brittany L. Snyder & Perry J. Blackshear. (2022) Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases. Pharmacology & Therapeutics 239, pages 108198.
Crossref
Xiaohui Su, Bei Yuan, Xueying Tao, Wanyi Guo, Xia Mao, Anguo Wu, Qian Wang, Chunfang Liu, Yanqiong Zhang, Xiangying Kong, Lan Han & Na Lin. (2022) Anti-angiogenic effect of YuXueBi tablet in experimental rheumatoid arthritis by suppressing LOX/Ras/Raf-1 signaling. Journal of Ethnopharmacology 298, pages 115611.
Crossref
Que-Huong Tran, Quoc-Thai Nguyen, Thi-Thuy Nga Tran, Thanh-Dao Tran, Minh-Tri Le, Dieu-Thuong Thi Trinh, Van-Thanh Tran, Viet-Hung Tran & Khac-Minh Thai. (2022) Identification of small molecules as potential inhibitors of interleukin 6: a multi-computational investigation. Molecular Diversity.
Crossref
Rephany Fonseca Peixoto, Carlos Ewerton Maia Rodrigues, Pedro Henrique de Sousa Palmeira, Fernando Cézar Comberlang Queiroz Davis dos Santos, Tatjana Keesen de Souza Lima & Alessandra de Sousa Braz. (2022) Immune hallmarks of rheumatoid arthritis management: A brief review. Cytokine 158, pages 156007.
Crossref
Rocco Cancelliere, Alessio Di Tinno, Andrea Maria Di Lellis, Giorgio Contini, Laura Micheli & Emanuela Signori. (2022) Cost-effective and disposable label-free voltammetric immunosensor for sensitive detection of interleukin-6. Biosensors and Bioelectronics 213, pages 114467.
Crossref
Vincent Franke, Sophie Meyer, Gundula Gesine Schulze-Tanzil, Tobias Braun, Maria Kokozidou, Theodor Fischlein & Sandeep Silawal. (2022) Complement Regulation in Immortalized Fibroblast-like Synoviocytes and Primary Human Endothelial Cells in Response to SARS-CoV-2 Nucleocapsid Protein and Pro-Inflammatory Cytokine TNFα. Life 12:10, pages 1527.
Crossref
Soshi Takagi, Yumi Naito, Chiaki Sano & Ryuichi Ohta. (2022) Secondary Failure of Tocilizumab in Treating Elderly-Onset Rheumatoid Arthritis With Systemic Symptoms Complicated by Diverticulum Perforation. Cureus.
Crossref
Linda A. Russell, Chad Craig, Eva K. Flores, J. Njeri Wainaina, Maureen Keshock, Mary J. Kasten, David L. Hepner, Angela F. Edwards, Richard D. Urman, Karen F. Mauck & Adriana D. Oprea. (2022) Preoperative Management of Medications for Rheumatologic and HIV Diseases: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clinic Proceedings 97:8, pages 1551-1571.
Crossref
Yonggan Ying, Zhaopeng Tang, Feng Niu, Taotao Xu, Chenjie Xia & Shuijun Zhang. (2022) Network pharmacology-based pharmacological mechanism prediction on Eucommia ulmoides against rheumatoid arthritis. Medicine 101:29, pages e29658.
Crossref
Yoichi Kurosawa, Satoshi Ito, Shunsuke Sakai, Eriko Hasegawa, Daisuke Kobayashi, Asami Abe, Hiroshi Otani, Kiyoshi Nakazono, Akira Murasawa, Ichiei Narita & Hajime Ishikawa. (2022) Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis. Internal Medicine 61:14, pages 2117-2125.
Crossref
Qaiser Jabeen, Syed Ihtisham Haider, Awais Asif, Rubina Rasheed, Shaheen Gul & Shafia Arshad. (2022) Geranium wallichianum D. Don Ex Sweet Ameliorates Rheumatoid Arthritis by Curtailing the Expression of COX-II and Inflammatory Cytokines as Well as by Alleviating the Oxidative Stress . Dose-Response 20:3, pages 155932582211126.
Crossref
Anthony Bonavia & Nicholas Stiles. (2022) Renohepatic crosstalk: a review of the effects of acute kidney injury on the liver. Nephrology Dialysis Transplantation 37:7, pages 1218-1228.
Crossref
Rossana Roncato, Jacopo Angelini, Arianna Pani & Rossella Talotta. (2022) Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1867:6, pages 159140.
Crossref
Muhammad Usman Saleem, Faqir Muhammad, Ali Sharif, Muhammad Imran Arshad, Kanwal Akhtar, Yasir Javed & Bushra Akhtar. (2022) Methotrexate-loaded biodegradable nanoparticles exert anti-arthritic effect by downregulating pro-inflammatory cytokines in Freund’s complete adjuvant-induced arthritic rats. Inflammopharmacology 30:3, pages 1079-1091.
Crossref
Charis L. Himeda & Peter L. Jones. (2022) FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?. Journal of Personalized Medicine 12:6, pages 865.
Crossref
Tatjana Zekić, Mirjana Stanić Benić & Mislav Radić. (2022) Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease. Rheumatology International 42:10, pages 1665-1679.
Crossref
Akito Ohkubo, Takashi Osoegawa, Naohiko Harada, Yoichiro Iboshi, Yorinobu Sumida, Makoto Nakamuta, Eiichi Suematsu, Hiroyuki Kobayashi & Eikichi Ihara. (2022) A Rare Case of Rheumatoid Arthritis with Tocilizumab-induced Intestinal Mucosal Injury. Internal Medicine 61:7, pages 1011-1014.
Crossref
Ki-Kwang Oh, Md. Adnan & Dong-Ha Cho. (2022) Drug Investigation to Dampen the Comorbidity of Rheumatoid Arthritis and Osteoporosis via Molecular Docking Test. Current Issues in Molecular Biology 44:3, pages 1046-1061.
Crossref
Susumu Hama, Naoko Kirimura, Aki Obara, Hirokatsu Takatsu & Kentaro Kogure. (2022) Tocopheryl Phosphate Inhibits Rheumatoid Arthritis-Related Gene Expression In Vitro and Ameliorates Arthritic Symptoms in Mice. Molecules 27:4, pages 1425.
Crossref
Qingyi Lu, Haixu Jiang, Qingqing Zhu, Jie Xu, Yanan Cai, Guiyang Huo, Kai Yuan, Guangrui Huang & Anlong Xu. (2022) Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Wael Hafez, Mohamad Azzam Ziade, Arun Arya, Husam Saleh, Mahmoud Abdelshakor, Osman Fadl Alla, Pragati Agrawal, Sara Ali, Srinivasa Raghu Rao, Subrata Gupta, Ikram Abdelli, Honeymol Sebastian, Mohamed Ali, Muneir Gador, Ziad Al Baha & Ahmed Abdelrahman. (2022) Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study. Antibiotics 11:2, pages 241.
Crossref
Daniel J Rawle, Thuy T Le, Troy Dumenil, Cameron Bishop, Kexin Yan, Eri Nakayama, Phillip I Bird & Andreas Suhrbier. (2022) Widespread discrepancy in Nnt genotypes and genetic backgrounds complicates granzyme A and other knockout mouse studies. eLife 11.
Crossref
Rosana Rodrigues Marana, Victor Augusto Benedicto dos Santos, Francisco C. Groppo, Luiz Eduardo N. Ferreira, Jonny B. Sánchez, Thomas Barbin & Sidney R. Figueroba. (2022) Omega 3 polyunsaturated fatty acids: Potential anti-inflammatory effect in a model of ovariectomy and temporomandibular joint arthritis induction in rats. Archives of Oral Biology 134, pages 105340.
Crossref
Philip Conaghan, Stanley Cohen, Gerd Burmester, Eduardo Mysler, Peter Nash, Yoshiya Tanaka, William Rigby, Jayeshkumar Patel, Tim Shaw, Keith A. Betts, Pankaj Patel, Jianzhong Liu, Rochelle Sun & Roy Fleischmann. (2021) Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis. Rheumatology and Therapy 9:1, pages 191-206.
Crossref
Marilyn Gros, Andreia M. Nunes, Douglas Daoudlarian, Jonathan Pini, Emanuela Martinuzzi, Susana Barbosa, Monique Ramirez, Angela Puma, Luisa Villa, Michele Cavalli, Nicolae Grecu, Jérémy Garcia, Gabriele Siciliano, Guilhem Solé, Raul Juntas-Morales, Peter L. Jones, Takako Jones, Nicolas Glaichenhaus & Sabrina Sacconi. (2022) Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy. Journal of Neuromuscular Diseases 9:1, pages 83-93.
Crossref
Thomas Jouve, Caroline Laheurte, Johan Noble, Jules Weinhard, Mélanie Daligault, Adeline Renaudin, Hamza Naciri Bennani, Dominique Masson, Eléonore Gravelin, Mathilde Bugnazet, Béatrice Bardy, Paolo Malvezzi, Philippe Saas & Lionel Rostaing. (2022) Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates. American Journal of Transplantation 22:1, pages 71-84.
Crossref
Chen Qian, Jie Chen, Xiaopeng Xu, Qingyang Liu, Minhong Gu, Sheng Lu, Hongxia Bai, Qiubo Wang & Mingyu Xue. (2021) Measurement of synovium and serum dual specificity phosphatase 22 level: Their inter‐correlation and potency as biomarkers in rheumatoid arthritis. Journal of Clinical Laboratory Analysis 36:1.
Crossref
Devy Zisman, Mirna Safieh, Elina Simanovich, Joy Feld, Amalia Kinarty, Liron Zisman, Tal Gazitt, Amir Haddad, Muna Elias, Itzhak Rosner, Lisa Kaly & Michal A. Rahat. (2021) Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147. Frontiers in Immunology 12.
Crossref
Helena Enocsson, Jesper Karlsson, Hai-Yun Li, Yi Wu, Irving Kushner, Jonas Wetterö & Christopher Sjöwall. (2021) The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus. Journal of Clinical Medicine 10:24, pages 5837.
Crossref
Ronald Man Lung Yip & Cheuk Wan Yim. (2021) Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 27:8, pages e516-e524.
Crossref
John Stack & Geraldine McCarthy. (2021) Calcium pyrophosphate deposition (CPPD) disease – Treatment options. Best Practice & Research Clinical Rheumatology 35:4, pages 101720.
Crossref
Hidetoshi Nara & Rin Watanabe. (2021) Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism. International Journal of Molecular Sciences 22:18, pages 9889.
Crossref
Jianqiao Hong, Zihao Qu, Xiaoxiao Ji, Congsun Li, Geng Zhang, Ciliang Jin, Jie Wang, Yongxing Zhang, Yue Shen, Jiahong Meng, Chenhe Zhou, Chaohua Fang, Wei Wang & Shigui Yan. (2021) Genetic Associations Between IL-6 and the Development of Autoimmune Arthritis Are Gender-Specific. Frontiers in Immunology 12.
Crossref
Quentin Miagoux, Vidisha Singh, Dereck de Mézquita, Valerie Chaudru, Mohamed Elati, Elisabeth Petit-Teixeira & Anna Niarakis. (2021) Inference of an Integrative, Executable Network for Rheumatoid Arthritis Combining Data-Driven Machine Learning Approaches and a State-of-the-Art Mechanistic Disease Map. Journal of Personalized Medicine 11:8, pages 785.
Crossref
Yin-Huai Chen, Diane B. Zastrow, Riley D. Metcalfe, Lisa Gartner, Freia Krause, Craig J. Morton, Shruti Marwaha, Laure Fresard, Yong Huang, Chunli Zhao, Colleen McCormack, David Bick, Elizabeth A. Worthey, Christine M. Eng, Jessica Gold, Undiagnosed Diseases Network, Stephen B. Montgomery, Paul G. Fisher, Euan A. Ashley, Matthew T. Wheeler, Michael W. Parker, Veerabahu Shanmugasundaram, Tracy L. Putoczki, Dirk Schmidt-Arras, Arian Laurence, Jonathan A. Bernstein, Michael D.W. Griffin & Holm H. Uhlig. (2021) Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome. Journal of Allergy and Clinical Immunology 148:2, pages 585-598.
Crossref
Mengmeng Zhao, Maowei Yang, Xu Li, Linxin Hou, Xudong Liu & Weiguo Xiao. (2021) Acid Sphingomyelinase and Acid β-Glucosidase 1 Exert Opposite Effects on Interleukin-1β-Induced Interleukin 6 Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. Inflammation 44:4, pages 1592-1606.
Crossref
Sai Krishna Srimadh Bhagavatham, Prakash Khanchandani, Vishnu Kannan, Damodaram Potikuri, Divya Sridharan, Sujith Kumar Pulukool, Ashwin Ashok Naik, Rajesh Babu Dandamudi, Sai Mangala Divi, Ashish Pargaonkar, Rahul Ray, Saibharath Simha Reddy Santha, Polani B. Seshagiri, K. Narasimhan, Narsimulu Gumdal & Venketesh Sivaramakrishnan. (2021) Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis. Scientific Reports 11:1.
Crossref
Rakesh Kumar Chauhan, Pramod Kumar Sharma & Shikha Srivastava. (2021) The Role of Signaling Pathway in the Biological Cause of Rheumatoid Arthritis. Current Drug Research Reviews 13:2, pages 130-139.
Crossref
Mahdi Taghadosi, Mehrnoosh Adib, Ahmadreza Jamshidi, Mahdi Mahmoudi & Elham Farhadi. (2021) The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Immunologic Research 69:3, pages 225-238.
Crossref
Hyery Kim, Seungwon You, Yoomi Park, Jung Yoon Choi, Youngeun Ma, Kyung Tak Hong, Kyung-Nam Koh, Sunmin Yun, Kye Hwa Lee, Hee Young Shin, Suehyun Lee, Keon Hee Yoo, Ho Joon Im, Hyoung Jin Kang & Ju Han Kim. (2021) Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT. Scientific Reports 11:1.
Crossref
Hilde Berner Hammer, Inger Marie Jensen Hansen, Pentti Järvinen, Marjatta Leirisalo-Repo, Michael Ziegelasch, Birte Agular & Lene Terslev. (2021) Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission. Rheumatology Advances in Practice 5:2.
Crossref
Jiaying Sun, Siming Dai, Ling Zhang, Yajing Feng, Xin Yu & Zhiyi Zhang. (2020) Investigating the safety and compliance of using csDMARDs in rheumatoid arthritis treatment through face-to-face interviews: a cross-sectional study in China. Clinical Rheumatology 40:5, pages 1789-1798.
Crossref
Morgan MacBeth, Anthony Joetham, Erwin W. Gelfand & Michaela Schedel. (2021) Plasticity of Naturally Occurring Regulatory T Cells in Allergic Airway Disease Is Modulated by the Transcriptional Activity of Il-6. International Journal of Molecular Sciences 22:9, pages 4582.
Crossref
Florian B. Imhoff, David E. Bauer & Ilker Uçkay. 2021. Bone and Joint Infections. Bone and Joint Infections 139 150 .
Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding & Sepideh Afshar. (2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. International Journal of Molecular Sciences 22:6, pages 2805.
Crossref
Matteo Calligaris, Doretta Cuffaro, Simone Bonelli, Donatella Pia Spanò, Armando Rossello, Elisa Nuti & Simone Dario Scilabra. (2021) Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution. Molecules 26:4, pages 944.
Crossref
Jianbo Tian, Ming Zhang, Meng Jin, Fengqin Zhang, Qian Chu, Xiaoyang Wang, Can Chen, Huihui Yue, Li Zhang, Ronghui Du, Dong Zhao, Zhaofu Zeng, Yang Zhao, Kui Liu, Mengmei Wang, Ke Hu, Xiaoping Miao & Huilan Zhang. (2021) Repurposed Tocilizumab in Patients with Severe COVID-19. The Journal of Immunology 206:3, pages 599-606.
Crossref
Tamir Baram, Linor Rubinstein-Achiasaf, Hagar Ben-Yaakov & Adit Ben-Baruch. (2021) Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. Frontiers in Oncology 10.
Crossref
JoannaL Moore, StephanieJ Stroever, PatriciaE Rondain & RobynN Scatena. (2021) Incidence of secondary bacterial infections following utilization of tocilizumab for the treatment of COVID-19 – A matched retrospective cohort study. Journal of Global Infectious Diseases 13:2, pages 67.
Crossref
Alina Klein & Yair Molad. (2021) Hematological Manifestations among Patients with Rheumatic Diseases. Acta Haematologica 144:4, pages 403-412.
Crossref
Livia L. Camargo, Alexandre Denadai-Souza, Lidia M. Yshii, Carla Lima, Simone A. Teixeira, Anderson R.A. Cerqueira, Mayara C.F. Gewehr, Elizabeth S. Fernandes, André A. Schenka, Marcelo N. Muscará, Emer S. Ferro & Soraia K.P. Costa. (2021) The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis. European Journal of Pharmacology 890, pages 173636.
Crossref
Xiaolong Liu, Jun Zhao, Ce Shi, Zhiyu Liu, Hongtao Shen, Junlong Dang, Yang Li, Dongguang Yang, Jia Wei, Liqing Kang, Jin Zhou, Fenglin Cao, Song Guo Zheng & Zhenkun Wang. (2020) Construction of CII-Specific CAR-T to Explore the Cytokine Cascades Between Cartilage-Reactive T Cells and Chondrocytes. Frontiers in Immunology 11.
Crossref
Changmin Choi, Wooseong Jeong, Byeongzu Ghang, Yonggeun Park, Changlim Hyun, Moonjae Cho & Jinseok Kim. (2020) Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Research & Therapy 22:1.
Crossref
Sofia Serena Tsakali & Catherine M. Shanahan. (2020) Calcinosis: insights from other calcinoses. Current Opinion in Rheumatology 32:6, pages 472-478.
Crossref
Grainne M Murray, Sebastiaan J Vastert & Athimalaipet V Ramanan. (2020) Aiming high: quantifying inflammation in systemic onset juvenile idiopathic arthritis (sJIA), a multi-faceted and complex inflammatory disease. Rheumatology 59:11, pages 3124-3126.
Crossref
Sumona Bhattacharya, Hastings Williamson, Amanda K. Urban, Theo Heller & Alexandra F. Freeman. (2020) Spontaneous Gastrointestinal Perforations in STAT3-Deficient Hyper-IgE Syndrome. Journal of Clinical Immunology 40:8, pages 1199-1203.
Crossref
Costantino Pitzalis, Ernest H. S. Choy & Maya H. Buch. (2020) Transforming clinical trials in rheumatology: towards patient-centric precision medicine. Nature Reviews Rheumatology 16:10, pages 590-599.
Crossref
María Clara Álvarez Ferreira, Vanina Alejandra Alamino, Cristina del Valle Acosta, Laura Beatriz Onetti, Eduardo Daniel Musssano, Isaac Ignacio Cadile, Estefanía Raquel Zacca, Adriana Gruppi, Eva Virginia Acosta Rodriguez & Paola Virginia Ferrero. (2020) Serum levels of Interleukin 22 and Interleukin 6 decrease after treatment in patients with rheumatoid arthritis. Revista Argentina de Reumatología, pages 40-50.
Crossref
Ana Copaescu, Olivia Smibert, Andrew Gibson, Elizabeth J. Phillips & Jason A. Trubiano. (2020) The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. Journal of Allergy and Clinical Immunology 146:3, pages 518-534.e1.
Crossref
Synat Keam, Dewi Megawati, Shailesh Kumar Patel, Ruchi Tiwari, Kuldeep Dhama & Harapan Harapan. (2020) Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection. Reviews in Medical Virology 30:5.
Crossref
Wen Shi Lee, Masaru Kato, Eri Sugawara, Michihiro Kono, Yuki Kudo, Michihito Kono, Yuichiro Fujieda, Toshiyuki Bohgaki, Olga Amengual, Kenji Oku, Shinsuke Yasuda, Tomohiro Onodera, Norimasa Iwasaki & Tatsuya Atsumi. (2020) Protective Role of Optineurin Against Joint Destruction in Rheumatoid Arthritis Synovial Fibroblasts. Arthritis & Rheumatology 72:9, pages 1493-1504.
Crossref
Jacob R. Greenmyer, John M. Stacy, Abe E. Sahmoun, James R. Beal & Erdal Diri. (2020) DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis. ACR Open Rheumatology 2:9, pages 507-511.
Crossref
Nicola De Rossi, Cristina Scarpazza, Chiara Filippini, Cinzia Cordioli, Sarah Rasia, Chiara Rosa Mancinelli, Damiano Rizzoni, Giuseppe Romanelli, Stefania Cossi, Nereo Vettoretto, Sergio Bove, Silvano Manfredini, Eva Andrea Beindorf, Carlo Mosca, Vittorio Scipione, Gigliola Flamminio, Elena Albini Albini, Paola Giansiracusa & Ruggero Capra. (2020) Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up. EClinicalMedicine 25, pages 100459.
Crossref
Salvatore Crisafulli, Valentina Isgrò, Laura La Corte, Fabiola Atzeni & Gianluca Trifirò. (2020) Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks. BioDrugs 34:4, pages 415-422.
Crossref
Marcelo Henrique Napimoga, Weslley Danny Dantas Formiga, Henrique Ballassini Abdalla, Carlos Antônio Trindade-da-Silva, Camila Motta Venturin, Elizabeth Ferreira Martinez, Ana Carolina Rossaneis, Waldiceu A. VerriJr.Jr. & Juliana Trindade Clemente-Napimoga. (2020) Secreted Osteoclastogenic Factor of Activated T Cells (SOFAT) Is Associated With Rheumatoid Arthritis and Joint Pain: Initial Evidences of a New Pathway. Frontiers in Immunology 11.
Crossref
Spinello Antinori, Cecilia Bonazzetti, Guido Gubertini, Amedeo Capetti, Cristina Pagani, Valentina Morena, Sara Rimoldi, Laura Galimberti, Piercarlo Sarzi-Puttini & Anna Lisa Ridolfo. (2020) Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?. Autoimmunity Reviews 19:7, pages 102564.
Crossref
Cosmin I. Ciotu & Michael J. M. Fischer. (2020) Novel Analgesics with Peripheral Targets. Neurotherapeutics 17:3, pages 784-825.
Crossref
Yulia Liubomirski & Adit Ben-Baruch. (2020) Notch-Inflammation Networks in Regulation of Breast Cancer Progression. Cells 9:7, pages 1576.
Crossref
Grant W. Waterer, Jordi Rello & Richard G. Wunderink. (2020) COVID-19: First Do No Harm. American Journal of Respiratory and Critical Care Medicine 201:11, pages 1324-1325.
Crossref
Yong Chen, Fujuan Qiu, Beijia Yu, Yanjuan Chen, Fangfang Zuo, XiaoYu Zhu, Kutty Selva Nandakumar & Changhong Xiao. (2020) Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion. Molecular Therapy - Methods & Clinical Development 17, pages 1202-1214.
Crossref
Ruggero Capra, Nicola De Rossi, Flavia Mattioli, Giuseppe Romanelli, Cristina Scarpazza, Maria Pia Sormani & Stefania Cossi. (2020) Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia. European Journal of Internal Medicine 76, pages 31-35.
Crossref
Mikiko Kobayashi, Yuki Matsumoto, Hidetoshi Satomi, Ayako Tateishi, Maki Ohya, Ichiro Ito & Hiroyuki Kanno. (2020) The ratio of CD163-positive macrophages to Iba1-positive macrophages is low in the intima in the early stage of cutaneous arteritis. Immunologic Research 68:3, pages 152-160.
Crossref
Elyes Bouajina, Leith Zakraoui, Montassar Kchir, Samir Kochbati & Sofiene Baklouti. (2019) Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice. Clinical Rheumatology 39:5, pages 1449-1455.
Crossref
Melissa Lo Monaco, Pascal Gervois, Joel Beaumont, Peter Clegg, Annelies Bronckaers, Jean-Michel Vandeweerd & Ivo Lambrichts. (2020) Therapeutic Potential of Dental Pulp Stem Cells and Leukocyte- and Platelet-Rich Fibrin for Osteoarthritis. Cells 9:4, pages 980.
Crossref
Yen-Ju Lin, Martina Anzaghe & Stefan Schülke. (2020) Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells 9:4, pages 880.
Crossref
Stephan Blüml. (2020) Biologika und „small molecules“ bei der rheumatoiden ArthritisBiologicals and small molecules for rheumatoid arthritis. Zeitschrift für Rheumatologie 79:3, pages 223-231.
Crossref
Shutong Li, Hongxing Wang, Hui Wu & Xiaotian Chang. (2020) Therapeutic Effect of Exogenous Regulatory T Cells on Collagen-induced Arthritis and Rheumatoid Arthritis. Cell Transplantation 29, pages 096368972095413.
Crossref
Ilya Ayzenberg, Simon Faissner, Laura Tomaske, Daniel Richter, Volker Behrendt & Ralf Gold. (2019) General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNS. Neurological Research and Practice 1:1.
Crossref
Yoshishige Miyabe, Jeffrey Lian, Chie Miyabe & Andrew D. Luster. (2019) Chemokines in rheumatic diseases: pathogenic role and therapeutic implications. Nature Reviews Rheumatology 15:12, pages 731-746.
Crossref
Ekaterina I. Alekseeva, Dariya D. Van’kova, Margarita A. Soloshenko, Tatyana M. DvoryakovskayaKseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy & Natalya E. Tkachenko. (2019) Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review. Current Pediatrics 18:2, pages 101-108.
Crossref
Rocco Cancelliere, Alessio Di Tinno, Andrea Maria Di Lellis, Giorgio Contini, Laura Micheli & Emanuela Signori. (2022) A Disposable Label-Free Voltammetric Immunosensor for Sensitive Detection of Interleukin-6.A Disposable Label-Free Voltammetric Immunosensor for Sensitive Detection of Interleukin-6. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.